ACM
TECH icon

Allred Capital Management’s Bio-Techne TECH Stock Holding History

Allred Capital Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-424
Closed -$40.5K – 698
2021
Q1 		$40.5K Buy
+424
New +$38.7K 0.02% 423

Other funds holding TECH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Allred Capital Management's TECH Position: Q2 2021 in Review

Allred Capital Management sold out of Bio-Techne (TECH) in Q2 2021, closing a stake of 424 shares — an estimated $40.5K sold.

Allred Capital Management first reported a position in TECH in Q1 2021 and held it in 1 quarter. The position peaked at $40.5K in Q1 2021. 511 funds tracked by Wall St. Rank hold TECH as of Q2 2021.

  • Allred Capital Management reported no remaining Bio-Techne position as of Q2 2021 after selling out during the quarter.
  • Allred Capital Management sold 424 Bio-Techne shares in Q2 2021, an estimated $40.5K.
  • Allred Capital Management first reported a position in Bio-Techne in Q1 2021 and held it in 1 quarter.
  • Allred Capital Management's Bio-Techne position peaked at $40.5K in Q1 2021.
  • 511 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2021.

Based on Allred Capital Management's 13F filing for Q2 2021, filed 5 Aug 2021.